Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
Biomica Ltd.
🇮🇱
Israel
Country
🇮🇱
Israel
Ownership
Subsidiary
Established
2016-02-01
Employees
11
Market Cap
-
Website
http://www.biomicamed.com
Clinical Trials
Related News
A First-in-human (FIH) Combination Treatment Study With a Single Dose Level of BMC128
Phase 1
Active, not recruiting
Conditions
Non-small Cell Lung Cancer
Melanoma
Renal Cell Carcinoma
Interventions
Drug: BMC128
Drug: Nivolumab
Subscribe
First Posted Date
2022-04-29
Last Posted Date
2024-05-07
Lead Sponsor
Biomica Ltd.
Target Recruit Count
11
Registration Number
NCT05354102
Locations
🇮🇱
Rambam MC, Haifa, Israel
Subscribe
Prev
1
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy